| Bruce Thompson brings more than 25 years of experience to his position as Chief Technology Officer. Bruce is the Founding CEO of Kincell where he built the technical and operations team and launched Kincell’s tech-savvy CDMO offerings in the marketplace. Prior to his role with Kincell, Bruce was Vice President and Technical Lead for the Cell Therapy Franchise at Resilience, Inc., where he helped to build the development and GMP manufacturing capabilities and served as a technical advisor.
Bruce has over 18 years of CMC strategy, product development and cell therapy manufacturing experience. As Vice President of Process Sciences at Lyell Immunopharma, he was responsible for Process and Analytical Development, as well as tech transfer of processes and methods to a newly built state-of-the-art cGMP facility. Before Lyell, Bruce served as the Sr. Director of the Therapeutic Products Program at Fred Hutchinson Cancer Research Center (FHCRC), where he led GMP manufacturing of cell and gene therapy products. He supported more than 15 active clinical programs and contributed to the filing of 6 INDs for various cell therapy programs. Bruce also spent nearly 10 years at Pfizer in the Pharmaceutical Sciences division where he gained expertise in analytical and process development. Bruce received his B.A. in Biology, an M.S. in Biochemistry from The Ohio State University and Ph.D. in Microbiology and Immunology from the University of Louisville. |
Archives: Speakers
Thomas Heathman
Tom currently serves as the Chief Commercial Officer for Ori Biotech, responsible for commercial launch of Ori’s technology, the IRO Platform, including deployments to initial customer base of Pharma and CDMOs. Prior to this, Tom served as the Business Leader for North America for Minaris Regenerative Medicine, a leading CDMO for the ATMP industry. During his time with Minaris, he led the growth of the North America business including the signing of commercial manufacturing agreements with leading therapy developers. Tom has a PhD in Cell and Gene Therapy Manufacturing from Loughborough University in the UK.